Virtual Clinical Trials Market in Asia Pacific would register a CAGR of 7.9% during 2020-2026

Published Date: 22-Dec-2020

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Asia Pacific Virtual Clinical Trials Market, published by KBV research, the Asia Pacific Virtual Clinical Trials Market would witness market growth of 7.9% CAGR during the forecast period (2020-2026).

The China market dominated the Asia Pacific Virtual Clinical Trials Market by Country in 2019, and would continue to be a dominant market till 2026. The Japan market is experiencing a CAGR of 8.9% during (2020 - 2026). Additionally, The India market is poised to grow at a CAGR of 8.9% during (2020 - 2026).

The Oncology market dominated the South Korea Virtual Clinical Trials Market by Indication in 2019, growing at a CAGR of 6.6 % during the forecast period. The Cardiovascular market is estimated to grow at a CAGR of 6.8% during (2020 - 2026). Additionally, The Immunology market is expected to witness highest CAGR of 9.6% during (2020 - 2026).

The Interventional market dominated the Malaysia Virtual Clinical Trials Market by Study Type in 2019, thereby, achieving a market value of $53.4 million by 2026. The Observational market is witnessing a CAGR of 9.3% during (2020 - 2026). Additionally, The Expanded Access market would showcase highest CAGR of 10.6% during (2020 - 2026).

Structural Insights: https://www.kbvresearch.com/asia-pacific-virtual-clinical-trials-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of IQVIA Holdings, Inc., ICON PLC, Laboratory Corporation of America Holdings (Covance, Inc.), Dassault Systemes SE (Medidata Solutions, Inc.), Oracle Corporation, Parexel International Corporation (Pamplona Capital Management), PRA Health Sciences, Inc. (KKR & Co., Inc.), Medpace Holdings, Inc., Medable, Inc. and Clinical Ink, Inc. (G.I. Partners).

Asia Pacific Virtual Clinical Trials Market Segmentation

By Study Type

  • Interventional
  • Observational
  • Expanded Access
  • Others

By Indication

  • Oncology
  • Cardiovascular
  • Immunology
  • Gastrointestinal
  • Respiratory
  • Endocrinology
  • Ophthalmology
  • Other Indications

By Country

  • China Virtual Clinical Trials Market
  • Japan Virtual Clinical Trials Market
  • India Virtual Clinical Trials Market
  • South Korea Virtual Clinical Trials Market
  • Singapore Virtual Clinical Trials Market
  • Malaysia Virtual Clinical Trials Market
  • Rest of Asia Pacific Virtual Clinical Trials Market

Companies Profiled

  • IQVIA Holdings, Inc.
  • ICON PLC
  • Laboratory Corporation of America Holdings (Covance, Inc.)
  • Dassault Systemes SE (Medidata Solutions, Inc.)
  • Oracle Corporation
  • Parexel International Corporation (Pamplona Capital Management)
  • PRA Health Sciences, Inc. (KKR & Co., Inc.)
  • Medpace Holdings, Inc.
  • Medable, Inc.
  • Clinical Ink, Inc. (G.I. Partners)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Virtual Clinical Trials Market Related Reports:

Global Market

North America Market

Europe Market

LAMEA Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.